Caplight Directory>Companies>Metcela Inc.-preview>Metcela


Metcela Inc.

Metcela Inc.

Private
KawasakiHealthcare & Life Scienceshttps://www.metcela.com/

Last Round

Series C

Jun 29, 2022

Total Funding Raised

$32.73M

Momentum Score

25 /100

Company Overview

Metcela Inc. is a biotechnology company that researches and develops fibroblast and stem cell-based therapies for cardiac diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

autologous cell therapyregenerative medicineheart failure therapyregen medcardiac fibroblastsVCFMTC001cell therapycardiac repairfibroblast platformVCAM-1-positive cardiac fibroblastsischemic cardiomyopathyclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Metcela Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Metcela Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CJun 29, 2022
Series BJan 4, 2021
Series AAug 30, 2018
SeedSep 19, 2017
View all Funding Rounds

Metcela Inc. Investors

Notable investors and investment history

InvestorRounds
Shinsei Capital PartnersSeries C
F-Prime CapitalSeries A, Series B
UTEC (The University of Tokyo Edge Capital Partners)Series B
Eight Roads Ventures JapanSeries A, Series B
Beyond Next VenturesSeries A, Seed
MAKOTO CapitalSeries B
Osaka University Venture Capital Co., Ltd.Series C
View all Investors

Metcela Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Metcela Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Metcela Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersKawasaki
Employee Range6
Year Founded2016
Last FundingJun 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.